US 2014/0294791 A1Published application

Lactobacillus paracasei subsp. paracasei, as an agent for inhibiting listeria monocytogenes in vivo infection

AssigneesInstitut Pasteur, Compagnie Gervais Danone

InventorsTamara Smokvina, Gianfranco Grompone, Sophie Legrain-Raspaud, Cristel Archambaud, Marc Lecuit, Pascale Cossart

Life of this patent

Estimating the term…

Abstract

The present invention relates to the use of the probiotic strain of Lactobacillus paracasei subsp. paracasei deposited at the CNCM under the reference I-3689, for inhibiting in vivo infection by Listeria monocytogenes.

Claims15

Dependent claims

A Lactobacillus paracasei subsp. paracasei strain deposited with the CNCM (Collection Nationale De Cultures De Microorganismes) under Accession number I-3689.

Dependencies are inferred from the claim text.

Facts

Application: 14/361,736Filed 1 Dec 2011
Published: 2 Oct 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification14 codes

A61K 35/747
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs: lactobacilli, e.g. L. acidophilus or L. brevis
A23L 33/135
Using additives: bacteria or derivatives thereof, e.g. probiotics
A61P 31/02
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: local antiseptics
C12N 1/20
Microorganisms; Compositions thereof ; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of…:…

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results